Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Outcome Prediction
100%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Fluoride
100%
Racl
100%
Radium-223 Therapy
100%
Confidence Interval
75%
Hazard Ratio
75%
Overall Survival Progression-free Survival
50%
Overall Survival
25%
Progression-free Survival
25%
Standardized Uptake Value
25%
Bone Metastasis
25%
Percent Change
25%
Confirmed Cases
25%
Hormone-sensitive Prostate Cancer
25%
Skeletal-related Events
25%
Skeletal muscle Tumor
25%
Skeletal Tumor Burden
25%
Radium-223
25%
Fluoride Uptake
25%
Free Time
25%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Overall Survival
75%
Hazard Ratio
75%
Fluorine-18
75%
Progression Free Survival
75%
Bone Cancer
50%
Computed Tomography Studies
50%
Standardized Uptake Value
25%
Bone Metastasis
25%
Castration Resistant Prostate Cancer
25%
Radium Chloride Ra 223
25%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Progression Free Survival
100%
Fluorine 18
100%
Bone Cancer
66%
Bone Tumor
66%
Computed Tomography Studies
66%
Bone Metastasis
33%
Castration Resistant Prostate Cancer
33%
Radium Chloride Ra 223
33%